日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

T-cell receptors identified by a personalized antigen-agnostic screening approach target shared neoantigen KRAS Q61H.

通过个性化的抗原非依赖性筛选方法鉴定的 T 细胞受体靶向共同的新抗原 KRAS Q61H

Lennerz Volker, Doppler Christoph, Fatho Martina, Dröge Anja, Schaper Sigrid, Gennermann Kristin, Genzel Nadine, Plassmann Stephanie, Weismann David, Lukowski Samuel W, Bents Dominik, Beushausen Christina, Kriese Karen, Herbst Hermann, Seitz Volkhard, Hammer Rudolf, Adam Paul J, Eggeling Stephan, Wölfel Catherine, Wölfel Thomas, Hennig Steffen

Antitumor Activity of the IGF-1/IGF-2-Neutralizing Antibody Xentuzumab (BI 836845) in Combination with Enzalutamide in Prostate Cancer Models

IGF-1/IGF-2中和抗体Xentuzumab(BI 836845)联合恩扎卢胺在前列腺癌模型中的抗肿瘤活性

Weyer-Czernilofsky, Ulrike; Hofmann, Marco H; Friedbichler, Katrin; Baumgartinger, Rosa; Adam, Paul J; Solca, Flavio; Kraut, Norbert; Nguyen, Holly M; Corey, Eva; Liu, Gang; Sprenger, Cynthia C; Plymate, Stephen R; Bogenrieder, Thomas

Discovery Strategies to Maximize the Clinical Potential of T-Cell Engaging Antibodies for the Treatment of Solid Tumors

探索最大化T细胞结合抗体在实体瘤治疗中临床应用潜力的策略

Voynov, Vladimir; Adam, Paul J; Nixon, Andrew E; Scheer, Justin M

Application of in situ reverse trancriptase-polymerase chain reaction (RT-PCR) to tissue microarrays

原位逆转录-聚合酶链式反应(RT-PCR)在组织微阵列中的应用

Stamps, Alasdair C; Terrett, Jonathan A; Adam, Paul J